Levers and Barriers to Vaccinate against COVID-19 in the Multicultural Context of French Guiana: A Qualitative Cross-Sectional Survey among Health Care Workers
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Sampling and Procedure
2.3. Data Collection
2.4. Statistical Analysis
2.5. Ethics and Regulation
3. Results
3.1. Motivation to Be Vaccinated
3.2. Barriers to Vaccination
- (i)
- Efficacy: clinical trials were considered too short, with a lack of hindsight on the efficacy of vaccines against circulating variants-of-concern (VOC) and of interest (“not worth it if a mutant virus is emerging”, “the virus mutates quickly, vaccination will always lag behind the mutations”), and on the short-lived immunity;
- (ii)
- Reduction of transmission: if the vaccine does not allow for a minimum removal of barriers measures, then its value is limited, according to a number of respondents;
- (iii)
- Potential adverse effects: the lack of hindsight on the possible long-term consequences, the adverse events, the mechanism of the RNA vaccine (sometimes considered as “genetic manipulation”) led to a significant fear of the vaccine.
3.3. French Guianese Specificities to Be Considered for the Vaccination Campaign
3.3.1. Specificities of French Guiana Making Vaccination against COVID-19 Appropriate
- (i)
- The high prevalence of risk factors for severe COVID-19 (hypertension, diabetes, obesity, HIV infection);
- (ii)
- The “porous” borders with a risk of introducing VOC from neighboring countries;
- (iii)
- The impact of the pandemic in economic, social, and food insecurity terms (hunger is common during COVID-19 in very precarious neighborhoods [13]);
- (iv)
- And the weakness of the Guianese healthcare system. Indeed, according to many respondents, it is facing a chronic lack of human resources and infrastructure (especially in intensive care units), with a risk of rapid saturation.
3.3.2. The Need for Accessibility to Vaccination in Several Ways
3.3.3. A Concern about the Communication around the COVID-19 Vaccine
4. Discussion
4.1. Limitations
4.2. Concerns about Side Effects and Distrust of Health Authorities
4.3. The Vaccine: A Way Back to Normal?
4.4. HCWs’ Concern about the Feasibility of Vaccination throughout French Guiana and for All
4.5. A Multiculturality to Be Taken into Account
4.6. Findings Shared with the French Overseas Territories of the West Indies
4.7. A Fourth Wave Due to the Delta Variant in a Context of Low Vaccination Coverage
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Larson, H.J.; De Figueiredo, A.; Xiahong, Z.; Schulz, W.S.; Verger, P.; Johnston, I.; Cook, A.; Jones, N.S. The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey. EBioMedicine 2016, 12, 295–301. [Google Scholar] [CrossRef] [Green Version]
- Santé Publique France. Point Epidémiologique Régional Spécial COVID-19 au 3 Juin 2021; Santé Publique France: Cayenne, France, 2021.
- Santé Publique France. Point Epidémiologique Régional Spécial COVID-19 au 6 Août 2021; Santé Publique France: Cayenne, France, 2021.
- Ministry of Health. Le Tableau de Bord de la Vaccination. Ministère des Solidarités et de la Santé. 2021. Available online: https://solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/article/le-tableau-de-bord-de-la-vaccination (accessed on 9 August 2021).
- Vignier, N.; Brureau, K.; Granier, S.; Breton, J.; Michaud, C.; Gaillet, M.; Agostini, C.; Ballet, M.; Nacher, M.; Valdes, A.; et al. Attitudes towards the COVID-19 Vaccine and Willingness to Get Vaccinated among Healthcare Workers in French Guiana: The Influence of Geographical Origin. Vaccines 2021, 9, 682. [Google Scholar] [CrossRef]
- Kallel, H.; Resiere, D.; Houcke, S.; Hommel, D.; Pujo, J.M.; Martino, F.; Carles, M.; Mehdaoui, H. Critical care medicine in the French Territories in the Americas: Current situation and prospects. Rev. Panam. Salud Pública 2021, 45, e46. [Google Scholar] [CrossRef]
- Nacher, M.; Douine, M.; Gaillet, M.; Flamand, C.; Rousset, D.; Rousseau, C.; Mahdaoui, C.; Carroll, S.; Valdes, A.; Passard, N.; et al. Simultaneous dengue and COVID-19 epidemics: Difficult days ahead? PLoS Negl. Trop. Dis. 2020, 14, e0008426. [Google Scholar] [CrossRef]
- Léglise, I. Les langues parlées en Guyane: Une extraordinaire diversité, un casse-tête pour les institutions. Lang. Cité 2017, 29, 2–5. [Google Scholar]
- Epelboin, L.; Michaud, C.; Oberlis, M.; Bidaud, B.; Naudion, P.; Teissier, S.; Dudognon, L.; Fernandes, C.; Cochet, C.; Caspar, C.; et al. Covid-19 epidemic in isolated settlements of the French Amazonia: Another reality. Lett. Infect. 2021, 36. [Google Scholar]
- Epelboin, L.; Michaud, C.; Oberlis, M.; Bidaud, B.; Naudion, P.; Dudognon, L.; Fernandes, C.; Cochet, C.; Jacoud, E.; Douine, M.; et al. Epidemic of COVID-19 in remote areas of the French Amazon March 2020–April 2021: Another reality. Braz. Soc. Trop. Med. Rev. Soc. Bras. Med. Trop. (under publication).
- O’Brien, B.C.; Harris, I.B.; Beckman, T.J.; Reed, D.A.; Cook, D.A. Standards for Reporting Qualitative Research: A Synthesis of Recommendations. Acad Med. 2014, 89, 1245–1251. [Google Scholar] [CrossRef] [PubMed]
- DePaolo, C.A.; Wilkinson, K. Get Your Head into the Clouds: Using Word Clouds for Analyzing Qualitative Assessment Data. TechTrends 2014, 58, 38–44. [Google Scholar] [CrossRef]
- Basurko, C.; Benazzouz, B.; Boceno, C.; Dupart, O.; Souchard, E.; Trepont, A.; Cann, L.; Lair, F.; Douine, M.; Sanna, A.; et al. Hunger during the Covid-19 crisis in Cayenne (French Guiana) and its surroundings. Bull. Epidemiol. Hebd. 2020, 29, 582–588. [Google Scholar]
- Wilson, S.L.; Wiysonge, C. Social media and vaccine hesitancy. BMJ Glob. Heal. 2020, 5, e004206. [Google Scholar] [CrossRef]
- Karafillakis, E.; Dinca, I.; Apfel, F.; Cecconi, S.; Wűrz, A.; Takacs, J.; Suk, J.; Celentano, L.P.; Kramarz, P.; Larson, H.J. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine 2016, 34, 5013–5020. [Google Scholar] [CrossRef]
- Woodhead, C.; Onwumere, J.; Rhead, R.; Bora-White, M.; Chui, Z.; Clifford, N.; Connor, L.; Gunasinghe, C.; Harwood, H.; Meriez, P.; et al. Race, ethnicity and COVID-19 vaccination: A qualitative study of UK healthcare staff. Ethn. Health 2021, 1–20. [Google Scholar] [CrossRef] [PubMed]
- Holzmann-Littig, C.; Braunisch, M.; Kranke, P.; Popp, M.; Seeber, C.; Fichtner, F.; Littig, B.; Carbajo-Lozoya, J.; Allwang, C.; Frank, T.; et al. COVID-19 Vaccination Acceptance and Hesitancy among Healthcare Workers in Germany. Vaccines 2021, 9, 777. [Google Scholar] [CrossRef] [PubMed]
- Verger, P.; Scronias, D.; Dauby, N.; Adedzi, K.A.; Gobert, C.; Bergeat, M.; Gagneur, A.; Dubé, E. Attitudes of healthcare workers towards COVID-19 vaccination: A survey in France and French-speaking parts of Belgium and Canada, 2020. Eurosurveillance 2021, 26, 2002047. [Google Scholar] [CrossRef] [PubMed]
- Hall, V.J.; Foulkes, S.; Saei, A.; Andrews, N.; Oguti, B.; Charlett, A.; Wellington, E.; Stowe, J.; Gillson, N.; Atti, A.; et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study. Lancet 2021, 397, 1725–1735. [Google Scholar] [CrossRef]
- Flamand, C. Principaux Résultats de la Seconde Vague D’enquête CAP-COVID-Guyane (26 avril au 9 mai 2021). Institut Pasteur de Guyane. 2021. Available online: https://www.pasteur-cayenne.fr/principaux-resultats-de-la-seconde-vague-denquete-cap-covid-guyane-realisee-du-26-avril-au-9-mai-2021/ (accessed on 9 August 2021).
- Mueller, J.; Olivier, C.; Luevano, C.D.; Bouvet, E.; Abiteboul, D.; Pellissier, G.; Rouveix, E. Cross-sectional study on the seasonal flu and Covid-19 vaccination intentions of healthcare professionals: Which levers for vaccine promotion? Bull. Epidemiol. Hebd. 2021, 2, 2–9. [Google Scholar]
- Valmy, L.; Gontier, B.; Parriault, M.C.; Van Melle, A.; Pavlovsky, T.; Basurko, C.; Grenier, C.; Douine, M.; Adenis, A.; Nacher, M. Prevalence and predictive factors for renouncing medical care in poor populations of Cayenne, French Guiana. BMC Health Serv. Res. 2015, 16, 34. [Google Scholar] [CrossRef] [Green Version]
- INSEE. Atlas des Populations Immigrées en Guyane; INSEE: Paris, France, 2006; p. 32.
- Odonne, G.; Musset, L.; Cropet, C.; Philogene, B.; Gaillet, M.; Tareau, M.-A.; Douine, M.; Michaud, C.; Davy, D.; Epelboin, L.; et al. When local phytotherapies meet biomedicine. Cross-sectional study of knowledge and intercultural practices against malaria in Eastern French Guiana. J. Ethnopharmacol. 2021, 279, 114384. [Google Scholar] [CrossRef]
- Tareau, M.A.; Palisse, M.; Odonne, G. As vivid as a weed… Medicinal and cosmetic plant uses amongst the urban youth in French Guiana. J. Ethnopharmacol. 2017, 203, 200–213. [Google Scholar] [CrossRef]
- World Health Organization. WHO Traditional Medicine Strategy: 2014–2023; World Health Organization: Geneva, Switzerland, 2013; Available online: https://apps.who.int/iris/handle/10665/92455 (accessed on 1 July 2021).
- Célestine, A. Vaccination aux Antilles: Les Racines de l’échec; France Culture, Sous les Radars: Paris, France, 2021. [Google Scholar]
- Regional Health Agency of French Guiana. Covid-19. The COVID-19 Pro Letter of 13 August 2021; Regional Health Agency of French Guiana: Cayenne, France, 2021. [Google Scholar]
- Nacher, M.; Rousseau, C.; Succo, T.; Andrieu, A.; Gaillet, M.; Michaud, C.; Servas, V.; Douine, M.; Schaub, R.; Adenis, A.; et al. The Epidemiology of COVID 19 in the Amazon and the Guianas: Similarities, Differences, and International Comparisons. Front. Public Health 2021, 9, 586299. [Google Scholar] [CrossRef] [PubMed]
- Elliott, P.; Haw, D.; Wang, H.; Eales, O.; Walters, C.; Ainslie, K.; Atchison, C.; Fronterre, C.; Diggle, P.; Page, A.; et al. REACT-1 Round 13 Final Report: Exponential Growth, High Prevalence of SARS-CoV-2 and Vaccine Effectiveness Associated with Delta Variant in England during May to July 2021; Imperial College London: London, UK, 2021; Available online: http://spiral.imperial.ac.uk/handle/10044/1/90800 (accessed on 9 August 2021).
- Kupferschmidt, K.; Wadman, M. Delta variant triggers new phase in the pandemic. Science 2021, 372, 1375–1376. [Google Scholar] [CrossRef]
All Included | Answering Qualitative Questions | % Who Answered Qualitative Questions | p-Value (chi2) | |||||
---|---|---|---|---|---|---|---|---|
n | % | n | % | % | ||||
N | 579 | 357 | 61.6 | |||||
Sex | ||||||||
Female | 393 | 67.9% | 242 | 67.8% | 61.6% | 0.977 | ||
Male | 186 | 32.1% | 115 | 32.2% | 61.8% | |||
Age | ||||||||
18–34 | 187 | 32.3% | 106 | 29.7% | 56.7% | 0.458 | ||
35–49 | 198 | 34.2% | 113 | 31.7% | 57.1% | |||
50–64 | 152 | 26.3% | 107 | 30.0% | 70.4% | |||
≥65 | 42 | 7.3% | 31 | 8.7% | 73.8% | |||
Profession | ||||||||
Physician | 220 | 38.0% | 156 | 43.7% | 70.9% | 0.112 | ||
Nurse | 217 | 37.5% | 121 | 33.9% | 55.8% | |||
Midwife | 24 | 4.1% | 17 | 4.8% | 70.8% | |||
Pharmacist | 17 | 2.9% | 11 | 3.1% | 64.7% | |||
Nurse supervisor | 17 | 2.9% | 7 | 2.0% | 41.2% | |||
Health care assistant | 9 | 1.6% | 1 | 0.3% | 11.1% | |||
Administrative | 30 | 5.2% | 7 | 2.0% | 2.3% | |||
Other * | 45 | 7.8% | 37 | 10.4% | 8.2% | |||
Place of birth | overall p-value: 0.985 | |||||||
France | 488 | 84.3% | 307 | 86.0% | 62.9% | |||
French Guiana | 115 | 19.9% | 60 | 16.8% | 52.2% | p-value for respondents born in France: 0.515 | ||
Mainland France | 346 | 59.8% | 230 | 64.4% | 66.5% | |||
French West indies | 18 | 3.1% | 13 | 3.6% | 72.2% | |||
other oversea French territory | 9 | 1.6% | 4 | 1.1% | 44.4% | |||
Europe | 17 | 2.9% | 10 | 2.8% | 58.8% | |||
Belgium, Netherlands, Spain, United Kingdom | ||||||||
America | 23 | 4.0% | 12 | 3.4% | 52.2% | |||
Argentina, Brazil, Colombia, Guyana, Peru, Suriname, Trinidad, Uruguay, USA, Venezuela | ||||||||
Africa | 39 | 6.7% | 25 | 7.0% | 64.1% | |||
North Africa | 11 | 28.2% | 8 | 32.0% | 72.7% | |||
Algeria, Morocco, Tunisia | ||||||||
Africa other-unspecified | 28 | 71.8% | 17 | 68.0% | 60.7% | |||
Benin, Cameron, Chad, Congo-Brazzaville, Democratic Republic of Congo, Guinea Bissau, Ivory Coast, Madagascar, Mali, Senegal, Togo | ||||||||
Asia | 4 | 0.7% | 2 | 0.6% | 50.0% | |||
India, Laos, Thailand |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Douine, M.; Granier, S.; Brureau, K.; Breton, J.; Michaud, C.; Gaillet, M.; Agostini, C.; Ballet, M.; Nacher, M.; Valdes, A.; et al. Levers and Barriers to Vaccinate against COVID-19 in the Multicultural Context of French Guiana: A Qualitative Cross-Sectional Survey among Health Care Workers. Vaccines 2021, 9, 1216. https://doi.org/10.3390/vaccines9111216
Douine M, Granier S, Brureau K, Breton J, Michaud C, Gaillet M, Agostini C, Ballet M, Nacher M, Valdes A, et al. Levers and Barriers to Vaccinate against COVID-19 in the Multicultural Context of French Guiana: A Qualitative Cross-Sectional Survey among Health Care Workers. Vaccines. 2021; 9(11):1216. https://doi.org/10.3390/vaccines9111216
Chicago/Turabian StyleDouine, Maylis, Sibylle Granier, Kepha Brureau, Jacques Breton, Céline Michaud, Mélanie Gaillet, Camille Agostini, Mathilde Ballet, Mathieu Nacher, Audrey Valdes, and et al. 2021. "Levers and Barriers to Vaccinate against COVID-19 in the Multicultural Context of French Guiana: A Qualitative Cross-Sectional Survey among Health Care Workers" Vaccines 9, no. 11: 1216. https://doi.org/10.3390/vaccines9111216
APA StyleDouine, M., Granier, S., Brureau, K., Breton, J., Michaud, C., Gaillet, M., Agostini, C., Ballet, M., Nacher, M., Valdes, A., Abboud, P., Adenis, A., Djossou, F., Epelboin, L., & Vignier, N. (2021). Levers and Barriers to Vaccinate against COVID-19 in the Multicultural Context of French Guiana: A Qualitative Cross-Sectional Survey among Health Care Workers. Vaccines, 9(11), 1216. https://doi.org/10.3390/vaccines9111216